ici 204,219 has been researched along with Constriction, Pathological in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlén, B | 1 |
| Roquet, A | 1 |
| Inman, MD | 1 |
| Karlsson, O | 1 |
| Naya, I | 1 |
| Anstrén, G | 1 |
| O'Byrne, PM | 1 |
| Dahlén, SE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Trial of Marine Lipid Fraction PCSO-524™ on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction in Asthma[NCT01504646] | 20 participants (Actual) | Interventional | 2012-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ici 204,219 and Constriction, Pathological
| Article | Year |
|---|---|
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
Topics: Bronchial Diseases; Constriction, Pathologic; Cross-Over Studies; Double-Blind Method; Drug Therapy, | 2002 |